low-dose human chorionic gonadotropin adjunct to an antagonist protocol in assisted reproductive technology: a randomized trial study.
نویسندگان
چکیده
the aim of this study was to evaluate the outcomes of adding low-dose hcg (human chorionic gonadotropin), as an lh active supplement, to a gnrh antagonist protocol in patients undergoing assisted reproduction techniques. in this parallel-group randomized clinical trial, 137 infertile female outpatients aged 20 - 39 years were randomized into two groups: hcg group and non-hcg group. all patients received r-fsh (150-300 iu) and then a gnrh-antagonist, cetrorelix (0.25 mg/day). concomitantly with cetrorelix, patients in the hcg group received low-dose hcg (200 iu daily), but the patients in the non-hcg group did not. 10,000 iu urinary hcg (10,000 iu) was injected to all patients, and icsi was performed after oocyte retrieval. the primary outcome of this study was comparing the pregnancy rates between two study groups. other differences between two groups such as serum estradiol concentration, fertilization rate, etc. were considered as secondary outcomes. a total of 130 patients completed this trial. no significant difference was detected between pregnancy rates of the two groups (p=0.52) as well as the fertilization, implantation and ongoing pregnancy rates (p=0.11, p=0.75 and p=0.06 respectively). the only significant difference between two groups was a higher concentration of estradiol in the hcg-treated patients (p<0.05). hcg-treated patients experienced a shorter treatment duration and a lower r-fsh required dose than the non-hcg group, but none of these differences were statistically significant (p=0.19 and p=0.10, respectively). the findings of the current study did not support advantages of adding low-dose hcg to gnrh antagonist plus r-fsh protocol in an unselected population of patients. well-designed trials with a larger sample size for specific patients' subgroups are warranted.
منابع مشابه
P-228: Low Dose HCG Adjunct to r-hFSH/GnRH Antagonist for Controlled Ovarian Stimulation in Assisted Reproductive Technology: A Prospective and Randomized Trial
Background: Deep suppression of LH in GnRH antagonist cycles may have detrimental effect on reproductive out come. It was hypnotized that adding LH activity via the administration of low dose HCG in late follicular phase shortened the duration of stimulation, decreased consumption of gonadotropin and increased estrogen levels. This study was designed to evaluate the effect of adding low dose HC...
متن کاملA review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology
Gonadotropins extracted from the urine of post-menopausal women have traditionally been used to stimulate folliculogenesis in the treatment of infertility and in assisted reproductive technology (ART). Products, such as human menopausal gonadotropin (hMG), consist not only of a mixture of the hormones, follicle-stimulating hormone (FSH), luteinising hormone (LH) and human chorionic gonadotropin...
متن کاملEffect of Adding Human Chorionic Gonadotropin to The Endometrial Preparation Protocol in Frozen Embryo Transfer Cycles
متن کامل
Flexible Multi-dose GnRH Antagonist versus Long GnRH Agonist Protocol in Poor Responders: A Randomized Controlled Trial
Background To compare a flexible, multi-dose GnRH antagonist protocol with a long GnRH .agonist protocol in poor respo MaterialsAndMethods A randomized clinical trial of 70 poor responder patients (35 patients in GnRH antagonist protocol and 35 patients in long GnRH agonist protocol) was performed at Royan Institute, Tehran, Iran. Both groups were given a fixed dose of human menopausal gonadotr...
متن کاملLow-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.
In previous studies of testicular biopsy tissue from healthy men, intratesticular testosterone (ITT) has been shown to be much higher than serum testosterone (T), suggesting that high ITT is needed relative to serum T for normal spermatogenesis in men. However, the quantitative relationship between ITT and spermatogenesis is not known. To begin to address this issue experimentally, we determine...
متن کاملEffect of Low-dose Human Chorionic Gonadotropin on the Prevention of Ovarian Hyperstimulation Syndrome and in Vitro Fertilization Outcome
Background & aim: Ovarian hyperstimulation syndrome (OHSS) is a rare but most potentially life-threatening disorder in women under in vitro fertilization (IVF). This study aimed to determine the effect of low-dose human chorionic gonadotropin (hCG) on the prevention of OHSS and IVF outcome. Methods: This single-blind non-randomized clinical trial was performed from October 2008 to November 2012...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
acta medica iranicaجلد ۵۲، شماره ۶، صفحات ۴۳۰-۴۳۷
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023